RNA Immunoprecipitation (RIP) Service
Inquiry
RNA Immunoprecipitation (RIP) is a powerful and versatile technique designed to capture these native, physiological interactions directly from cell or tissue lysates, without the need for crosslinking. At CD BioSciences, we offer comprehensive RIP services, from hypothesis-driven validation of specific RNA targets to unbiased, genome-wide discovery of RBP interactomes. Our optimized protocols, stringent controls, and deep sequencing expertise provide you with reliable, publication-ready data to decipher the complex landscape of post-transcriptional regulation.
Mechanism of RNA Immunoprecipitation (RIP)
RNA Immunoprecipitation (RIP) is a foundational technique designed to capture a snapshot of the native RNA-protein interactome within cells. Its core mechanism involves the gentle crosslinking and stabilization of protein-RNA complexes inside intact cells, followed by the specific immunopurification of a target RNA-binding protein (RBP) along with its bound RNA cargoes. Subsequent isolation and analysis of these co-precipitated RNAs reveal the direct molecular partnerships that govern post-transcriptional fate.
Fig.1 RNA immunoprecipitation done by targeting RBPs. (Head S R, et al., 2014)
Applications of RNA Immunoprecipitation (RIP) Genome-Wide RIP-Seq ServiceTechnology
The principal advantage and significance of RIP lie in its ability to analyze interactions within their native cellular context. Unlike in vitro binding assays, RIP preserves the physiological environment, including correct protein folding, post-translational modifications, and the presence of co-factors or competing molecules, thereby providing a more biologically relevant interaction profile. This makes it an indispensable tool for:
- Discovering in vivo RNA targets of a protein of interest.
- Validating interactions predicted by computational methods or high-throughput screens.
- Studying dynamic changes in RBP-RNA networks in response to stimuli, during differentiation, or in disease states.
- Laying the groundwork for more detailed mechanistic studies on specific regulatory pairs.
Our Services
Accurately defining an RBP's RNA targets is foundational to understanding its mechanism. Inefficient lysis, antibody non-specificity, and RNA degradation during the procedure can lead to high background, false positives, and loss of genuine signals. Our service is built to overcome these challenges. We employ rigorously validated antibodies and optimized lysis buffers that maintain RNP integrity while effectively solubilizing complexes. Our protocol includes multiple negative controls (e.g., IgG control, bead-only control) and, for RIP-Seq, an input RNA control to distinguish authentic enrichment from background noise. CD BioSciences provides two primary RIP service tiers, allowing you to choose the right approach for your research stage and budget.
Our RIP Service Portfolio
Genome-Wide RIP-Seq Service
For discovery-phase research, our RIP-Seq service provides an unbiased, transcriptome-wide view of all RNAs associated with your RBP of interest. Following the immunoprecipitation, the recovered RNA is converted into a sequencing library and subjected to high-depth next-generation sequencing (NGS). Advanced bioinformatics analysis then identifies all significantly enriched RNA species—including mRNAs, lncRNAs, and circRNAs. This approach is powerful for identifying novel RBP targets, defining binding preferences, and understanding the global impact of an RBP on the RNA landscape.
Sample Requirements & Experimental Design
We are flexible and can work with a variety of sample types, including cultured cell lines (adherent or suspension), primary cells, and frozen tissue samples. During the project consultation phase, our experts will work with you to determine the optimal sample amount based on your RBP's expression level and the chosen method (qPCR vs. Seq). We strongly recommend the use of a high-quality, validated antibody for the target RBP. We can source the antibody for you or use a client-provided antibody, subject to validation checks. We also assist in designing critical experimental controls, which are essential for data interpretation.
Standard RIP-qPCR Service
This service is ideal for validating suspected interactions or monitoring changes in RBP binding to a predefined set of RNA targets under different conditions. We use your specified, validated antibodies to immunoprecipitate the target RBP from your provided lysates. The co-precipitated RNA is then purified and analyzed via quantitative RT-PCR using your primer sets. This service delivers precise, quantitative data on the enrichment of specific transcripts, perfect for focused mechanistic studies, time-course experiments, or testing the effects of mutations or drug treatments on known interactions.
Our Detection & Analysis Platforms
This highly sensitive method precisely measures the enrichment of known or candidate RNA targets, ideal for validating specific interactions or conducting focused quantitative studies.
RIP-Chip enables unbiased, genome-wide profiling of protein-bound RNA populations, efficiently identifying coding and non-coding RNA targets across the entire transcriptome.
High-Throughput Sequencing (RIP-seq)
RIP-seq provides the most complete, unbiased discovery of all bound RNA species, including novel transcripts and isoforms, with full bioinformatic analysis of the interactome.
This classical technique offers direct visualization and size confirmation of specific RNAs, particularly useful for analyzing long or structurally complex non-coding RNA targets.
Supported Sample Types
- Cultured Cells & Primary Cells. A wide range of cell types are supported, including adherent and suspension mammalian cell lines, as well as primary cells isolated from various tissues (cell count and viability information required).
- Fresh or Frozen Tissue Samples. Tissue specimens from animal models or clinical sources, optimally snap-frozen in liquid nitrogen or preserved in suitable RNA stabilization reagents to maintain RNA-protein interactions.
- Cellular & Nuclear Extracts. Pre-prepared whole-cell lysates, cytoplasmic extracts, or nuclear extracts. We also accept IP-ready lysates provided by the client, subject to quality control assessment.
- Genetically Modified or Treated Samples. Cells expressing epitope-tagged proteins (e.g., FLAG-, HA-, MYC-tagged RBPs) for immunoprecipitation with tag-specific antibodies. Samples from specific disease models or subjected to drug treatments, cytokine stimulation, or other perturbations are also supported.
Our RIP Workflow
Our streamlined, five-step workflow ensures robust and reproducible capture of native RNA-protein complexes, transforming your samples into reliable, actionable data.
Consultation & Custom Design
We collaborate with you to define the project scope, including target protein, cell type/tissue, desired readout (qPCR, microarray, or sequencing), and necessary controls (e.g., IgG control, input RNA, no-antibody control).
Antibody Validation & Optimization
We can validate your antibody for RIP suitability or recommend/provide validated antibodies. We optimize lysis and wash conditions for your specific sample type.
Sample Preparation & QC
Starting from your provided cell lines, tissue samples, or IP-ready lysates. We perform quality checks (e.g., cell viability, protein/RNA integrity) before proceeding.
RIP Execution & RNA Isolation
The complete RIP procedure is performed under RNase-free conditions. Co-precipitated RNA is rigorously purified and assessed for quality and quantity.
Analysis & Comprehensive Reporting
RNA is analyzed via the chosen platform. The final report includes detailed protocols, QC data, raw and analyzed results (e.g., qPCR Ct values, RIP-seq alignment files, lists of enriched RNAs), and a professional interpretation of the findings.
Why Choose Us?
- Native State Preservation. Our optimized native lysis buffers maximize the recovery of intact, functional RNP complexes without crosslinking artifacts, providing a true picture of steady-state interactions.
- Rigor & Specificity. We implement multiple layers of controls (Isotype IgG, no-antibody, and input RNA controls) and stringent wash conditions to ensure the identified interactions are specific and reproducible.
- Platform Flexibility & Expertise. We seamlessly handle projects ranging from focused qPCR validation to genome-wide sequencing, providing expert guidance on the most cost-effective and informative path for your goals.
- Integrated Bioinformatics. Our dedicated RIP-Seq analysis pipeline is tailored to identify enriched transcripts from native IP data, incorporating advanced normalization and statistical models to deliver high-confidence target lists.
Frequently Asked Questions (FAQs)
Q1: What is the main difference between RIP and CLIP?
A: RIP isolates native, non-crosslinked complexes, reflecting more stable, functional interactions. CLIP uses UV crosslinking to covalently "freeze" direct interactions, including transient ones, allowing for precise binding site mapping but under non-native conditions. The choice depends on whether you seek functional complexes (RIP) or precise binding sites (CLIP).
Q2: What antibody is suitable for RIP?
A: The ideal antibody is one that has been previously validated for immunoprecipitation under native conditions. We recommend checking literature or databases. We can also perform pilot tests to validate client-provided antibodies.
Q3: Can RIP detect indirect RNA associations (via other proteins or complexes)?
A: Yes, this is a key feature. Because it is performed without crosslinking, RIP can co-precipitate RNAs that are part of larger RNP complexes, which is ideal for studying functional RNPs like spliceosomes or stress granules.
Q4: What are the sample requirements?
A: We typically require 1x10^7 cells or 50-100mg of frozen tissue per condition for a robust RIP-Seq experiment. Requirements for RIP-qPCR are lower and target-dependent. We provide specific guidelines upon consultation.
Q5: Do you provide the antibody?
A: We can source and validate antibodies for common RBPs. For novel or uncommon targets, we recommend clients provide the antibody, and we will assess its suitability for RIP.
Q6: What bioinformatics support is included with RIP-Seq?
A: Our standard analysis includes read processing, alignment, identification of enriched transcripts/regions, and basic functional enrichment. We also offer advanced custom analyses, such as integration with RNA-seq or CLIP-seq data, for an additional fee.
CD BioSciences' RNA Immunoprecipitation (RIP) Service delivers robust, high-quality data to empower your research into RNA-protein interactions and post-transcriptional regulation. By combining optimized, reliable protocols with versatile detection platforms—from targeted qPCR to genome-wide RIP-seq—and backed by rigorous controls and expert data interpretation, we provide the insights needed to validate interactions, discover novel targets, and unravel complex regulatory mechanisms. Contact us today to discuss your specific project and develop a customized experimental plan.
Reference
1. Head S R, Komori H K, LaMere S A, et al. Library construction for next-generation sequencing: overviews and challenges[J]. Biotechniques, 2014, 56(2): 61-77.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
